Sanford Health has provided $23m in funding to increase the regenerative cell therapy provider's series D round to $43m, having initially supplied the first $20m in 2017.

US-based regenerative medicine and cell therapy technology developer InGeneron extended its series D round to $43m on Tuesday with a $23m investment from hospital operator Sanford Health. The corporate had provided the initial $20m in March 2017 as part of a cooperation agreement and has structured the capital in various tranches based on the company‚Äôs…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.